Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-098192
Filing Date
2016-02-12
Accepted
2016-02-12 17:41:59
Documents
1
Period of Report
2016-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2162
  Complete submission text file 0001209191-16-098192.txt   3476
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Bonner Michael (Reporting) CIK: 0001666790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 161421343